Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP... see more

TSXV:HEM - Post Discussion

Hemostemix Inc > Have I got this right?
View:
Post by slingbo on Jul 09, 2021 12:43pm

Have I got this right?

Hemostemix contracted Aspire to conduct phase 2 and when HEm went into recievership Aspire cancelled the contract and retained data. Now that Hem has refinanced they are able to fulfil terms of contract. Could knowledgeable people comment if im interpteting this correctly?
Comment by Walterthedog on Jul 09, 2021 5:02pm
Not quite. Watch the CEOs videos on their site and read all the NRs for the last 5 years and you should have a pretty good idea of whats going on. It would take a long time to summarize and I would likely miss key points if i tried. Price will probably hover around here until either there is positive movement in the court cases or we are able to finally see the results of the phase 2 trial. I don& ...more  
Comment by ENEMENEMYNEMO on Jul 10, 2021 4:06pm
Not sure on the receivership bit but I thought Aspire failed to pay the $1million in partnership payments and Hemo pulled the plug on the deal. Aspire refused to hand over data they had and here we are....
Comment by slingbo on Jul 10, 2021 7:13pm
The CEO vid suggested by Walterthedog was well worth watching. Good background information on the unfolding drama in the courts.
Comment by TimBennethae on Jul 11, 2021 12:17pm
This post has been removed in accordance with Community Policy
Comment by Walterthedog on Jul 11, 2021 1:00pm
This post has been removed in accordance with Community Policy
Comment by Walterthedog on Jul 11, 2021 1:23pm
This post has been removed in accordance with Community Policy
Comment by TimBennethae on Jul 11, 2021 1:24pm
This post has been removed in accordance with Community Policy
Comment by Walterthedog on Jul 11, 2021 1:36pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse